---
figid: PMC6791449__koni-08-11-1657374-g006
figtitle: Evolution of CIN+ tumors
organisms:
- NA
pmcid: PMC6791449
filename: koni-08-11-1657374-g006.jpg
figlink: /pmc/articles/PMC6791449/figure/F0006/
number: F6
caption: Schematic model of the evolution of CIN+ tumors. CIN creates an immune pressure
  in the nascent tumor cells due to the activation of the STING pathway and subsequent
  innate anti-tumor response. This immune pressure allows for the selection of CIN+
  clones that have uncoupled genomic instability from the activation of the STING
  pathway activation and consequent immunostimulation. The resultant tumors are thus
  immunologically cold.
papertitle: Suppression of tumor antigen presentation during aneuploid tumor evolution
  contributes to immune evasion.
reftext: Reshmi Tripathi, et al. Oncoimmunology. 2019;8(11):1657374.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9483955
figid_alias: PMC6791449__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6791449__F6
ndex: 06d2d236-de9e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6791449__koni-08-11-1657374-g006.html
  '@type': Dataset
  description: Schematic model of the evolution of CIN+ tumors. CIN creates an immune
    pressure in the nascent tumor cells due to the activation of the STING pathway
    and subsequent innate anti-tumor response. This immune pressure allows for the
    selection of CIN+ clones that have uncoupled genomic instability from the activation
    of the STING pathway activation and consequent immunostimulation. The resultant
    tumors are thus immunologically cold.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CGAS
  - STING1
  - TBK1
  - IFNA1
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - TRIM63
  - HLA-C
  - tumor
---
